A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 33/24 (2006.01)
Patent
CA 2629036
A subject with symptoms of chronic kidney disease (CKD), who does not have end- stage renal disease (ESRD), can be treated by orally administering a pharmaceutical composition as an active ingredient a therapeutically effective amount of a non-toxic lanthanum compound. Administration of a lanthanum compound can prevent the progression of CKD, treat soft tissue calcification, and treat secondary hyperparathyroidism.
La présente invention concerne un sujet présentant des symptômes de néphropathie chronique (NC), ne présentant pas d'insuffisance rénale chronique terminale (IRCT) et pouvant être traité par une administration par voie orale d~une composition pharmaceutique comprenant en tant que principe actif, une dose thérapeutiquement efficace d~un composé de lanthane non toxique. L~administration d~un composé de lanthane peut prévenir la progression d~une IRCT et traiter la calcification des tissus mous et l~hyperparathyroïdisme secondaire.
Damment Stephen Jp
Pratt Raymond Dennis
Webster Isobel
Robic
Shire International Licensing B.v.
LandOfFree
Treatment of chronic kidney disease (ckd) subjects using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of chronic kidney disease (ckd) subjects using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of chronic kidney disease (ckd) subjects using... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1783113